23andMe Announces Business Restructuring to Streamline

Nov 11, 2024 · 23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future November 11, 2024 17:30 ET | Source: 23andMe, …

CouponFollow Extension

40%
OFF

23andMe Cuts 40% Of Its Workforce, Discontinues All Therapy …

2 weeks from now

Nov 11, 2024 · Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as …

cnn.com

40%
OFF

23andMe Cuts Headcount By 40%, Drops Drug Discovery Work

2 weeks from now

Nov 12, 2024 · Genetic testing company 23andMe announced on Monday that it will discontinue its development of new therapies, instead focusing on its genetic testing services and …

biospace.com

40%
OFF

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of …

2 weeks from now

Nov 12, 2024 · On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. ME announced a business restructuring to streamline operations and reduce costs.. In …

benzinga.com

$12
OFF

What’s Happening With 23andMe? Mass Layoffs And Restructuring …

2 weeks from now

Nov 12, 2024 · The layoffs are expected to result in $12 million in severance, termination, and transition-related costs and are part of a broader plan to streamline the business and achieve …

yahoo.com

40%
OFF

23andMe To Reduce Overall Headcount By 40% Of Workforce

2 weeks from now

Nov 11, 2024 · 23andMe Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing further development of all its …

businessinsider.com

40%
OFF

23andMe Announces Business Restructuring To Streamline …

2 weeks from now

Nov 11, 2024 · 23andMe announced a significant business restructuring, including the discontinuation of its therapeutics division and a 40% workforce reduction affecting over 200 …

stocktitan.net

40%
OFF

23andMe Reduces Workforce By 40% - Seeking Alpha

2 weeks from now

Nov 11, 2024 · 23andMe announces significant business restructuring to streamline operations and reduce costs, including laying off 40% of its workforce.

seekingalpha.com

40%
OFF

Troubled 23andMe Is Exploring A Sale Of The Business

2 weeks from now

Jan 29, 2025 · The move comes a few weeks after 23andMe announced sweeping job losses affecting around 40% of its headcount and an exit from the drug discovery and development …

pharmaphorum.com

98%
OFF

23andMe Might Sell Itself As It Runs Out Of Money - Quartz

2 weeks from now

Jan 29, 2025 · By the 2023 fiscal year, 23andMe reported a net loss of $312 million. The company’s individual share price is down 98% since 2021 to about $4, after a reverse stock …

qz.com

FAQs about 23andMe Announces Business Restructuring to Streamline Coupon?

Does 23andMe have a restructuring plan?

After Monday’s restructuring plan, the company expects annualized cost savings of more than $35 million. Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. ...

What happened to 23andMe?

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ: ME) announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing the further development of all its therapeutic programs while evaluating strategic alternatives for its clinical and preclinical assets. ...

Why is 23andMe rethinking its strategic options?

23andMe is actively exploring all strategic options in parallel with discontinuing its therapeutics division. 23andMe intends to wind down its ongoing clinical trials as quickly as practical while the strategic alternatives process continues. announced a business restructuring to streamline operations and reduce costs. ...

Does 23andMe Holding Co (me) have strategic alternatives?

Watch here. 23andMe Holding Co. (ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, including a potential sale, business combination, asset sales, restructuring, or other options, the company said in a statement. Warning! GuruFocus has detected 6 Warning Signs with ME. ...

What's next for 23andMe & its employees?

What’s next for 23andMe and its employees? The layoffs are expected to result in $12 million in severance, termination, and transition-related costs and are part of a broader plan to streamline the business and achieve annual cost savings of $35 million. ...

Why is 23andMe reducing its workforce?

In addition, 23andMe is discontinuing the further development of all its therapeutic programs while evaluating strategic alternatives for its clinical and preclinical assets. The company is reducing its overall headcount by over 200 employees, representing approximately 40% of the workforce. ...